Literature DB >> 25541324

Trends and predictors of smoking cessation after percutaneous coronary intervention (from Olmsted County, Minnesota, 1999 to 2010).

Ondrej Sochor1, Ryan J Lennon2, Juan Pablo Rodriguez-Escudero3, John F Bresnahan3, Ivana Croghan4, Virend K Somers3, Francisco Lopez-Jimenez3, Quinn Pack3, Randal J Thomas5.   

Abstract

Smoke-free ordinance implementation and advances in smoking cessation (SC) treatment have occurred in the past decade; however, little is known about their impact on SC in patients with coronary artery disease. We conducted a retrospective cohort study of 2,306 consecutive patients from Olmsted County, Minnesota, who underwent their first percutaneous coronary intervention (PCI) from 1999 to 2009, and assessed the trends and predictors of SC after PCI. Smoking status was ascertained by structured telephone survey 6 and 12 months after PCI (ending in 2010). The prevalence of smoking in patients who underwent PCI increased nonsignificantly from 20% in 1999 to 2001 to 24% in 2007 to 2009 (p = 0.14), whereas SC at 6 months after PCI decreased nonsignificantly from 50% (1999 to 2001) to 49% (2007 to 2009), p = 0.82. The 12-month quit rate did not change significantly (48% in 1999 to 2001 vs 56% in 2007 to 2009, p = 0.38), even during the time periods after the enactment of smoke-free policies. The strongest predictor of SC at 6 months after PCI was participation in cardiac rehabilitation (odds ratio [OR] 3.17, 95% confidence interval [CI] 2.05 to 4.91, p <0.001), older age (OR 1.42 per decade, 95% CI 1.16 to 1.73, p <0.001), and concurrent myocardial infarction at the time of PCI (OR 1.77, 95% CI 1.18 to 2.65, p = 0.006). One-year mortality was lower in the group of smokers compared with never smokers (3% vs 7%, p <0.001). In conclusion, SC rates have not improved after PCI over the past decade in our cohort, despite the presence of smoke-free ordinances and improved treatment strategies. Improvements in delivery of systematic services aimed at promoting SC (such as cardiac rehabilitation) should be part of future efforts to improve SC rates after PCI.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25541324     DOI: 10.1016/j.amjcard.2014.11.020

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Effect of Smoking Status on Exercise Perception and Intentions for Cardiac Rehabilitation Enrollment Among Patients Hospitalized With an Acute Cardiac Condition.

Authors:  Hayden Riley; Samuel Headley; Christa Winter; Sara Mazur; Diann E Gaalema; Sarah Goff; Peter K Lindenauer; Quinn R Pack
Journal:  J Cardiopulm Rehabil Prev       Date:  2018-09       Impact factor: 2.081

2.  Patient Perception of How Smoking Status Influences Cardiac Rehabilitation Attendance After an Acute Cardiac Hospitalization.

Authors:  Hayden Riley; Samuel Headley; Peter K Lindenauer; Sarah Goff; Heidi Szalai; Diann E Gaalema; Quinn R Pack
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-05       Impact factor: 2.081

Review 3.  Smoking cessation for secondary prevention of cardiovascular disease.

Authors:  Angela Difeng Wu; Nicola Lindson; Jamie Hartmann-Boyce; Azizia Wahedi; Anisa Hajizadeh; Annika Theodoulou; Elizabeth T Thomas; Charlotte Lee; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2022-08-08

4.  Life Years Gained From Smoking-Cessation Counseling After Myocardial Infarction.

Authors:  Emily M Bucholz; Adam L Beckman; Catarina I Kiefe; Harlan M Krumholz
Journal:  Am J Prev Med       Date:  2016-09-28       Impact factor: 5.043

5.  Trends in tobacco use among US adults with chronic health conditions: National Survey on Drug Use and Health 2005-2013.

Authors:  Cassandra A Stanton; Diana R Keith; Diann E Gaalema; Janice Y Bunn; Nathan J Doogan; Ryan Redner; Allison N Kurti; Megan E Roberts; Stephen T Higgins
Journal:  Prev Med       Date:  2016-04-15       Impact factor: 4.018

6.  A comparison of the impact of current smoking on 2-year major clinical outcomes of first- and second-generation drug-eluting stents in acute myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry.

Authors:  Yong Hoon Kim; Ae-Young Her; Myung Ho Jeong; Byeong-Keuk Kim; Sung-Jin Hong; Chul-Min Ahn; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Myeong-Ki Hong; Yangsoo Jang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

7.  Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: Assessing patient interest, confidence, and physician prescribing practices.

Authors:  Hayden Riley; Nitesh Ainani; Ahmad Turk; Samuel Headley; Heidi Szalai; Mihaela Stefan; Peter K Lindenauer; Quinn R Pack
Journal:  Clin Cardiol       Date:  2019-10-24       Impact factor: 2.882

8.  Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.

Authors:  Yong Hoon Kim; Ae-Young Her; Myung Ho Jeong; Byeong-Keuk Kim; Sung-Jin Hong; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Myeong-Ki Hong; Yangsoo Jang
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

9.  Determinants of persistent smoking after acute myocardial infarction: an observational study.

Authors:  Jens Höpner; Udo Junge; Andrea Schmidt-Pokrzywniak; Christian Fischer; Rafael Mikolajczyk
Journal:  BMC Cardiovasc Disord       Date:  2020-08-24       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.